Article
Nucleophosmin mutation in de-novo acute myeloid leukemia.
Asia-Pacific journal of clinical oncology - 1 Mar 2016
Rastogi Pulkit, Naseem Shano, Varma Neelam, Varma Subhash
Abstract excerpt
OBJECTIVE: Acute myeloid leukemia (AML) with mutated nucleophosmin gene (NPM1) has distinctive clinical, hematological and molecular features, and is included as a provisional entity in 2008 World Health Organization classification. In this study, we analyzed the frequency and features of AML with mutated NPM1 in Indian patients. METHODS: One-hundred consecutive patients of de-novo AML were evaluated for NPM1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
